IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis.

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Previous studies suggest Interleukin-9 (IL-9) influences intestinal barrier function.
• T cell-mediated colitis is a significant model for studying inflammatory bowel disease.

Purpose of the Study:

• To investigate the role of IL-9 in experimental T cell-mediated colitis induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS).
• To analyze the impact of IL-9 deficiency on intestinal barrier integrity and tight junction molecule expression.

Main Methods:

• Induction of colitis using TNBS in wild-type and IL-9 knockout (KO) mice.
• Analysis of T cell populations (PU.1 expressing T cells) in the lamina propria.
• Assessment of tight junction proteins (occludin, Claudin1, Claudin2) using real-time PCR, immunofluorescence, and Western blot.

Main Results:

• IL-9 deficiency suppressed TNBS-induced colitis and reduced PU.1 expressing T cells.
• Occludin expression was upregulated, while Claudin1 expression was downregulated in the inflamed colon of IL-9 KO mice.
• Claudin2 expression remained unchanged between wild-type and IL-9 KO mice.

Conclusions:

• IL-9 plays a pleiotropic role in regulating intestinal permeability during experimental colitis.
• Th9 cells appear to be regulatory in the TNBS colitis model.
• Targeting IL-9 function presents a potential therapeutic approach for intestinal inflammation and barrier repair.